Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2021
Historique:
pubmed: 4 5 2021
medline: 18 9 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

Stroke and dementia are interrelated diseases and risk for both increases with age. Even though stroke incidence and age-standardized death rates have decreased due to prevention of stroke risk factors, increased utilization of reperfusion therapies, and other changes in healthcare, the absolute numbers are increasing due to population growth and aging. To analyze predictors of death after stroke in patients with dementia and investigate possible time and treatment trends. A national longitudinal cohort study 2007-2017 using Swedish national registries. We compared 12,629 ischemic stroke events in patients with dementia with matched 57,954 stroke events in non-dementia controls in different aspects of patient care and mortality. Relationship between dementia status and dementia type (Alzheimer's disease and mixed dementia, vascular dementia, other dementias) and death was analyzed using Cox regressions. Differences in receiving intravenous thrombolysis between patients with and without dementia disappeared after the year 2015 (administered to 11.1% dementia versus 12.3% non-dementia patients, p = 0.117). One year after stroke, nearly 50% dementia and 30% non-dementia patients had died. After adjustment for demographics, mobility, nursing home placement, and comorbidity index, dementia was an independent predictor of death compared with non-dementia patients (HR 1.26 [1.23-1.29]). Dementia before ischemic stroke is an independent predictor of death. Over time, early and delayed mortality in patients with dementia remained increased, regardless of dementia type. Patients with≤80 years with prior Alzheimer's disease or mixed dementia had higher mortality rates after stroke compared to patients with prior vascular dementia.

Sections du résumé

BACKGROUND
Stroke and dementia are interrelated diseases and risk for both increases with age. Even though stroke incidence and age-standardized death rates have decreased due to prevention of stroke risk factors, increased utilization of reperfusion therapies, and other changes in healthcare, the absolute numbers are increasing due to population growth and aging.
OBJECTIVE
To analyze predictors of death after stroke in patients with dementia and investigate possible time and treatment trends.
METHODS
A national longitudinal cohort study 2007-2017 using Swedish national registries. We compared 12,629 ischemic stroke events in patients with dementia with matched 57,954 stroke events in non-dementia controls in different aspects of patient care and mortality. Relationship between dementia status and dementia type (Alzheimer's disease and mixed dementia, vascular dementia, other dementias) and death was analyzed using Cox regressions.
RESULTS
Differences in receiving intravenous thrombolysis between patients with and without dementia disappeared after the year 2015 (administered to 11.1% dementia versus 12.3% non-dementia patients, p = 0.117). One year after stroke, nearly 50% dementia and 30% non-dementia patients had died. After adjustment for demographics, mobility, nursing home placement, and comorbidity index, dementia was an independent predictor of death compared with non-dementia patients (HR 1.26 [1.23-1.29]).
CONCLUSION
Dementia before ischemic stroke is an independent predictor of death. Over time, early and delayed mortality in patients with dementia remained increased, regardless of dementia type. Patients with≤80 years with prior Alzheimer's disease or mixed dementia had higher mortality rates after stroke compared to patients with prior vascular dementia.

Identifiants

pubmed: 33935077
pii: JAD201459
doi: 10.3233/JAD-201459
pmc: PMC8293632
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1253-1261

Références

Neurology. 1985 Jun;35(6):834-40
pubmed: 4000483
Eur Stroke J. 2020 Mar;5(1):36-46
pubmed: 32232168
Neurology. 2011 Nov 1;77(18):1664-73
pubmed: 22042795
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Natl Vital Stat Rep. 2019 Mar;68(2):1-29
pubmed: 31112120
Psychogeriatrics. 2014 Sep;14(3):196-201
pubmed: 25323961
J Am Geriatr Soc. 2016 Nov;64(11):e137-e142
pubmed: 27801938
J Alzheimers Dis. 2018;66(1):185-194
pubmed: 30248059
J Neurol. 2012 Nov;259(11):2366-75
pubmed: 22532173
Curr Alzheimer Res. 2018;15(14):1322-1330
pubmed: 30280666
Med Care. 2016 Oct;54(10):907-12
pubmed: 27367867
Stroke. 2007 Apr;38(4):1384-6
pubmed: 17322093
Stroke. 1994 Oct;25(10):1915-9
pubmed: 8091433
Arch Neurol. 1994 Dec;51(12):1220-5
pubmed: 7986177
Stroke. 2001 Sep;32(9):2131-6
pubmed: 11546907
J Alzheimers Dis. 2014;41(2):467-77
pubmed: 24625796
BMC Neurol. 2014 Sep 30;14:195
pubmed: 25265943
Circulation. 2002 Mar 5;105(9):1082-7
pubmed: 11877359
J Neurol. 2003 Jan;250(1):10-6
pubmed: 12527986
Clin Epidemiol. 2019 Jul 16;11:525-542
pubmed: 31410066
Neurology. 2017 Oct 31;89(18):1860-1868
pubmed: 28986410
J Alzheimers Dis. 2018;61(3):1119-1128
pubmed: 29286925
Neurology. 2000 Jan 25;54(2):447-51
pubmed: 10668712
J Am Geriatr Soc. 1991 Jun;39(6):603-10
pubmed: 2037752
J Alzheimers Dis. 2020;73(3):1013-1021
pubmed: 31884483
Cerebrovasc Dis. 2005;20(4):239-44
pubmed: 16123543
Arch Neurol. 1998 Sep;55(9):1226-32
pubmed: 9740117
Arch Gerontol Geriatr. 1989 Sep-Oct;9(2):193-7
pubmed: 2589919
Br J Psychiatry. 1995 Oct;167(4):527-32
pubmed: 8829724
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
Circulation. 2010 Feb 23;121(7):879-91
pubmed: 20142445
Stroke Res Treat. 2018 Nov 27;2018:3238165
pubmed: 30598741
Stroke. 2014 Jan;45(1):315-53
pubmed: 24309587
J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104559
pubmed: 31836360
J Am Med Dir Assoc. 2018 Feb;19(2):154-161
pubmed: 28993049
Otolaryngol Clin North Am. 2013 Dec;46(6):1137-49
pubmed: 24262965
Neurology. 2002 Aug 27;59(4):537-43
pubmed: 12196645
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213

Auteurs

Eva Zupanic (E)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Department of Neurology, University Medical Centre, Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Mia von Euler (M)

Department of Neurology and Rehabilitation Medicine, Örebro University Hospital, Örebro, Sweden.
School of Medicine, Örebro University, Örebro, Sweden.

Bengt Winblad (B)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.

Hong Xu (H)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.

Juraj Secnik (J)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.

Milica Gregoric Kramberger (MG)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Department of Neurology, University Medical Centre, Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Dorota Religa (D)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.

Bo Norrving (B)

Neurology Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden.

Sara Garcia-Ptacek (S)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH